Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bingpeng Powder (Bing Peng San) is a traditional Chinese medicine (TCM) topical formulation used primarily for treating oral and throat conditions. It is composed of Borneolum Syntheticum (borneol), Borax, Cinnabar, and Natrii Sulfas Exsiccatus. The formula is designed to clear 'Toxic-Heat' and dispel putrescence, making it effective for recurrent oral ulcers (stomatocace), gingivitis, and sore throats. It is applied topically to the affected mucous membranes. While widely used in China and manufactured by companies like Tianjin Hong Ren Tang Pharmaceutical, it has been noted in safety reviews for potential adverse effects such as allergic contact dermatitis and risks associated with its cinnabar (mercuric sulfide) content.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bingpeng powder.